Earum Pharmaceuticals Ltd Q1 FY2022-23 net profit at Rs. 36.30 lakhs

has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 5.1444 crores during the period ended June 30, 2022 as compared to Rs. 10.1583 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 0.3630 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. -0.7160 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 0.29 for the period ended June 30, 2022 as compared to Rs. -0.12 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 5.1444 crs	₹10.1583 crs	-49.36%
Net Profit	₹0.3630 crs	₹-0.7160 crs	150.70%
EPS	₹0.29	₹-0.12	341.67%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 5.1444 crores during the period ended June 30, 2022 as compared to Rs.3.0701 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.0.3630 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.-3.7407 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.0.29 for the period ended June 30, 2022 as compared to Rs.-5.53 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 5.1444 crs	₹3.0701 crs	67.56%
Net Profit	₹0.3630 crs	₹-3.7407 crs	109.70%
EPS	₹0.29	₹-5.53	105.24%

Source : Equity Bulls

Keywords

EarumPharmaceuticals Q1FY23 ResultUpdate